$10.7 Million in Second Quarter Revenue, a 156% Increase Over Prior Year
$1.5 Million Adjusted EBITDA for Second Quarter
HENDERSON, Nev., Feb. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Grove, Inc. (NASDAQ:GRVI) ("Grove" or the "Company"), a global innovator in hemp, health, and wellness, today announced financial results for the second quarter period ended December 31, 2021. Investors are encouraged to read the Company’s quarterly report on Form 10-Q which will be filed with the Securities and Exchange Commission (the “SEC”), contains additional information, and will be posted at https://groveinc.io/.
Year to Date Financial Highlights
Revenues rose to $19.1 million from $7.1 million, a 167% increase.
$0.04 basic earnings per share compared to loss of $0.06.
$2.9 million in adjusted EBITDA.
103,750 shares of Grove common stock repurchased with cash flow from operations.
Allan Marshall, Chief Executive Officer of Grove, stated, “Our team continues to perform and drive growth across all parts of our business, with a 169% increase year over year even with substantial headwinds. We face shortages and rising prices on all raw materials, employee shortages, higher wages, drastic increases in shipping cost across all parts of the business. However, we were able to maintain growth and profits offsetting increased costs with higher volumes and pricing power.
“Our Upexi Amazon aggregation business launch is beginning to come together, and we are seeing multiple submissions a week from companies looking to be acquired. Our strong cash flow gives us great flexibility to expand the Brand aggregation business and become more active with acquisitions this year.”
Liquidity and Capital Resources
As of December 31, 2021
As of June 30, 2021
Current assets
$
12,097,966
$
18,293,083
Current liabilities
$
5,262,529
$
5,819,161
Working capital
$
6,835,437
$
12,473,922
Cash Flows
Six Months Ended December 31,
2021
2020
Cash flows provided by (used in) operating activities
$
1,212,609
$
(669,321
)
Cash flows (used in) provided by investing activities
(8,999,854
)
241,785
Cash flows (used in) financing activities
(151,004
)
738,000
Net decrease in cash during period
$
(7,938,249
)
$
310,464
About Grove, Inc.
Grove, Inc. is a global innovator in hemp, health and wellness. The company has an array of in-house brands, and operates in multiple verticals including SaaS programmatic ad technology, and a wholly owned division dedicated to acquiring high growth e-commerce brands. The company sells to numerous consumer markets including the botanical, beauty, pet care, and functional foods sectors. It seeks to take advantage of an emerging worldwide trend in consumer health products selling through Amazon and E-commerce.
Company Contact Andrew Norstrud Email: investorinfo@cbd.io Phone: (702) 332-5591
Investor Relations Contact TraDigital IR John McNamara Email: john@tradigitalir.com Phone: (917) 658-2602
Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements," including with respect to the Company's business strategy, product development and industry trends. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Use of Non-GAAP Financial Measures
The Company discloses and uses the above-mentioned non-GAAP financial measures internally as a supplement to GAAP financial information to evaluate its operating performance, for financial planning purposes, to establish operational goals, for compensation plans, to measure debt service capability, for capital expenditure planning and to determine working capital needs and believes that these are useful financial measures also used by investors. Non-GAAP adjusted EBITDA is defined as GAAP net income or net loss before interest, taxes, depreciation and amortization (EBITDA) adjusted for the non-cash stock compensation and stock option expense, acquisition, integration & restructuring expenses, charges and gains or losses from extinguishment of debt and other non-cash items. Non-GAAP EBITDA and non-GAAP adjusted EBITDA are not terms defined by GAAP and, as a result, the Company’s measure of non-GAAP EBITDA and non-GAAP adjusted EBITDA might not be comparable to similarly titled measures used by other companies. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position, or cash flow that either excludes or includes amounts that are not normally included in the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP financial measures discussed above, however, should be considered in addition to, and not as a substitute for, or superior to net income or net loss as reported for GAAP on the Consolidated Statements of Operations, cash and cash flows on the Consolidated Statement of Cash Flows or other measures of financial performance prepared in accordance with GAAP, and as reflected on the Company’s financial statements prepared in accordance with GAAP. These non-GAAP financial measures are not a substitute for or presented in lieu of financial measures provided by GAAP and all measures and disclosures of financial information pursuant to GAAP should be read to obtain a comprehensive and thorough understanding of the Company’s financial results. The reconciliations of non-GAAP EBITDA and non-GAAP adjusted EBITDA to GAAP operating income (loss) and/or GAAP net income (net loss) referred to in the highlights or elsewhere are provided in the schedules that are a part of this document.
Reconciliation of Non-GAAP Adjusted EBITDA to GAAP Net Income (Net Loss)
Six Months Ended December 31,
2021
2020
Net income (Net loss) GAAP
$
576,544
$
(706,553
)
Income tax
235,033
-
Interest expense, net
42,561
84,740
Depreciation and amortization
914,511
503,244
Stock compensation
1,479,293
354,817
Gain on SBA PPP loan extinguishment
(300,995
)
-
Loss on sale of asset
-
6,292
Non-GAAP adjusted EBITDA
$
2,946,947
$
(242,540
)
GROVE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
December 31,
June 30,
2021
2021
ASSETS
Current assets
Cash
$
6,595,962
$
14,534,211
Accounts receivable, net of allowance for doubtful accounts of $92,500 and $57,500, respectively
1,247,218
1,277,662
Inventory
3,681,428
2,094,952
Prepaid expenses and other receivables
573,358
386,258
Total current assets
12,097,966
18,293,083
Property and equipment, net
7440,332
2,832,400
Intangible assets, net
5,189,234
1,845,166
Goodwill
8,533,923
2,413,813
Deferred tax asset
1,225,917
1,403,591
Other assets
69,068
49,068
Right-of-use asset
648,626
417,443
Total other assets
23,107,100
8,961,481
Total assets
$
35,205,066
$
27,254,564
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable
$
895,846
$
1,604,723
Accrued compensation
679,000
1,020,936
Deferred revenue
959,329
485,973
Accrued liabilities
873,585
296,021
Acquisition payable
600,000
1,764,876
Current portion of notes payable
1,006,197
447,100
Current portion of operating lease payable
248,572
199,532
Total current liabilities
5,262,529
5,819,161
Operating lease payable, net of current portion
395,085
217,430
Notes payable, net of current portion
26,766
-
Total long-term liabilities
421,851
217,430
Commitments and contingencies
-
-
Stockholders' equity
Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 500,000 and 500,000 shares issued and outstanding, respectively
500
500
Common stock, $0.001 par value, 100,000,000 shares authorized, and 15,711,339 and 15,262,394 shares issued and outstanding, respectively
16,378
15,262
Additional paid in capital
33,097,300
25,372,247
Accumulated deficit
(3,593,492
)
(4,170,036
)
Total stockholders' equity
29,520,686
21,217,973
Total liabilities and stockholders' equity
$
35,205,066
$
27,254,564
GROVE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
